Beta 1 Integrin Signaling Mediates Pancreatic Ductal Adenocarcinoma Resistance to MEK Inhibition
A. Brannon, D. Drouillard, N. Steele, S. Sutherland, H. Crawford, M. Pasca di Magliano
This study identifies integrin β1 signaling as a mediator of MEK inhibitor resistance in pancreatic cancer organoids, suggesting combination therapy targeting both pathways.
bioRxiv · Jan 6, 2020Cancer Biology